相关实验视频

Updated: May 10, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

用米尔特福辛向CCR5作为对血小板缺血的治疗策略

Qinyao Li^1,2, Ting Zhang^1,3, Zhichao Li¹

¹Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China.

|April 28, 2025

概括

米尔特福辛通过刺激巨核细胞分化来促进血小板的产生. 这种药物向CCR5受体,激活关键的信号通路,以加速血小板恢复在条件,如血小板减少.

科学领域:

血液学血液学血液学
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

血小板缺血 presents显著的临床挑战与有限的治疗策略.
巨核细胞 (MK) 的分化对于血小板的产生至关重要,但其调节是复杂的.

研究的目的:

调查米尔特福辛对巨核细胞分化和血小板产生的影响.
阐明密尔特福辛的作用背后的分子机制,包括其与信号通路和潜在点的相互作用.

主要方法:

在MK分化的体外研究.
在体内实验中使用被辐射的小鼠来评估血小板恢复和功能.
RNA测序以识别相关的信号通路.
分子对接,DARTS和SPR测试以确认药物标结合.
针对CCR5,MAPK和JAK2/STAT3通路的抑制研究.

主要成果:

在体内,米尔特福辛显著增强了血小板恢复,功能和MK分化.
RNA测序确定了CCR5,MAPK和JAK2/STAT3信号通路,这些通路参与了米尔特福辛的作用.
米尔特福辛直接与CCR5结合,通过多项生化分析证实了这一点.
抑制CCR5,MAPK或JAK2/STAT3通路,取消了miltefosine的益血小板作用和转录因子激活.

结论:

米尔特福辛作为CCR5激动剂,促进MK分化和血小板的产生.
该机制涉及MAPK和JAK2/STAT3信号通路的激活.
已确定CCR5是治疗血小板缺血的一个可行的治疗点.

关键词:

免疫学免疫学免疫学分子生物学分子生物学

更多相关视频

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...